PATENT CLAIM ANALYSIS

Application Number: 15900169
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "044000"]

Abstract:
Provided herein are methods and compositions for the treatment of metabolic disorders. Also provided herein are methods and compositions for the reduction of blood glucose level, the reduction of gluceoneogenesis, the improvement of insulin resistance and the reduction of plasma cholesterol level. In certain embodiments, the methods comprise inhibiting the activity of miR-103. In certain embodiments, the methods comprise inhibiting the activity of miR-107. In certain embodiments, the activity of both miR-103 and miR-107 is inhibited. In certain embodiments, such methods comprise administering a compound comprising an oligonucleotide targeted to a microRNA.

Claim (Index 4):
The method of  claim 2 , comprising measuring the blood glucose level of the subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 2.21277
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14970959', '15375433', '14334868', '14061365', '13320873']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8479912053482734
- 35 USC 102 Novelty (BERT): 0.6173356362598773
- Combined Prediction Score: 0.8249256484394338
- Mean Citation Score: 641.7620079999998
- Max Citation Score: 644.7112400000002
- Similarity Product: 480.3005004948188

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test